In a significant shift in mosquito-borne disease trends, Chikungunya cases have now surpassed Dengue in Bhopal, raising red flags over possible underreporting and gaps in surveillance. As of July 2025, the city has continuted to have equally...
Apollo AyurVAID, a part of Apollo Hospitals Group, has announced the launch of India’s First line of “Tested Safe” Ayurveda products, setting a new benchmark in the traditional medicine space. The line includes classical prescription formulations...
As part of a major step to digitisation of India’s pharmaceutical regulatory processes, the Central Drugs Standard Control Organisation (CDSCO) announced that effective 15 July 2025, all applications for World Health Organisation Good Manufacturin...
.jpeg)
A new study has shown that many widely used generic chemotherapy medicines around the world have failed quality testing. This raises serious doubts about the safety and efficacy of cancer therapy in more than 100 countries. The affected drugs...
The Union Health Ministry is looking to tighten drug quality regulations by proposing to immediately suspend manufacturing licenses of pharmaceutical companies for drugs that fail government lab testing. The change follows a recommendation from...
Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...
In an interaction with India Pharma Outlook, Dr. Ganesh Babu, Head of Clinical and Regulatory Affairs at Carl Zeiss India, discusses how optical imaging technologies like fluorescence imaging and OCT are revolutionizing cancer detection. He highlight
India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...
Eli Lilly's experimental obesity drug, eloralintide, has shown promising early-stage data supporting weight loss of an average of 11.5 percent after only 12 weeks, said an investor note from Cantor Fitzgerald...
Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware
, CDSCO.jpg)
